These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
354 related articles for article (PubMed ID: 33177810)
1. Homoharringtonine Exerts an Antimyeloma Effect by Promoting Excess Parkin-Dependent Mitophagy. Zhang Y; Huang N; Xu J; Zheng W; Cui X Drug Des Devel Ther; 2020; 14():4749-4763. PubMed ID: 33177810 [TBL] [Abstract][Full Text] [Related]
2. PI3K/Akt inhibitor LY294002 potentiates homoharringtonine antimyeloma activity in myeloma cells adhered to stromal cells and in SCID mouse xenograft. Chen P; Wen X; Wang B; Hou D; Zou H; Yuan Q; Yang H; Xie J; Huang H Ann Hematol; 2018 May; 97(5):865-875. PubMed ID: 29450644 [TBL] [Abstract][Full Text] [Related]
3. Homoharringtonine inhibits the AKT pathway and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells. Meng H; Yang C; Jin J; Zhou Y; Qian W Leuk Lymphoma; 2008 Oct; 49(10):1954-62. PubMed ID: 18949618 [TBL] [Abstract][Full Text] [Related]
4. HPLC analysis of harringtonine and homoharringtonine in the needles of Cephalotaxus griffithii alkaloid fraction and cytotoxic activity on chronic myelogenous leukaemia K562 cell. Moirangthem DS; Borah JC; Laishram S; Kalita MC; Talukdar NC Nat Prod Res; 2014; 28(18):1503-6. PubMed ID: 24787645 [TBL] [Abstract][Full Text] [Related]
5. PEGylated long-circulating liposomes deliver homoharringtonine to suppress multiple myeloma cancer stem cells. Li M; Shi F; Fei X; Wu S; Wu D; Pan M; Luo S; Gu N; Dou J Exp Biol Med (Maywood); 2017 May; 242(9):996-1004. PubMed ID: 28056549 [TBL] [Abstract][Full Text] [Related]
6. Homoharringtonine suppresses LoVo cell growth by inhibiting EphB4 and the PI3K/AKT and MAPK/EKR1/2 signaling pathways. Shi X; Zhu M; Gong Z; Yang T; Yu R; Wang J; Zhang Y Food Chem Toxicol; 2020 Feb; 136():110960. PubMed ID: 31726078 [TBL] [Abstract][Full Text] [Related]
7. Anti-myeloma effect of homoharringtonine with concomitant targeting of the myeloma-promoting molecules, Mcl-1, XIAP, and beta-catenin. Kuroda J; Kamitsuji Y; Kimura S; Ashihara E; Kawata E; Nakagawa Y; Takeuichi M; Murotani Y; Yokota A; Tanaka R; Andreeff M; Taniwaki M; Maekawa T Int J Hematol; 2008 Jun; 87(5):507-515. PubMed ID: 18415656 [TBL] [Abstract][Full Text] [Related]
8. Curcumin in combination with homoharringtonine suppresses lymphoma cell growth by inhibiting the TGF-β/Smad3 signaling pathway. Zhang Y; Xiang J; Zhu N; Ge H; Sheng X; Deng S; Chen J; Yu L; Zhou Y; Shen J Aging (Albany NY); 2021 Jul; 13(14):18757-18768. PubMed ID: 34324434 [TBL] [Abstract][Full Text] [Related]
9. TMEM16A, a Homoharringtonine Receptor, as a Potential Endogenic Target for Lung Cancer Treatment. Guo S; Bai X; Shi S; Deng Y; Kang X; An H Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681590 [TBL] [Abstract][Full Text] [Related]
10. Homoharringtonine induces apoptosis and growth arrest in human myeloma cells. Lou YJ; Qian WB; Jin J Leuk Lymphoma; 2007 Jul; 48(7):1400-6. PubMed ID: 17613769 [TBL] [Abstract][Full Text] [Related]
11. Anti-varicella-zoster virus activity of cephalotaxine esters in vitro. Kim JE; Song YJ J Microbiol; 2019 Jan; 57(1):74-79. PubMed ID: 30456755 [TBL] [Abstract][Full Text] [Related]
12. Homoharringtonine enhances bortezomib antimyeloma activity in myeloma cells adhesion to bone marrow stromal cells and in SCID mouse xenografts. Chen P; Yuan Q; Yang H; Wen X; You P; Hou D; Xie J; Cheng Y; Huang H Leuk Res; 2017 Jun; 57():119-126. PubMed ID: 28463768 [TBL] [Abstract][Full Text] [Related]
13. Metabolism of homoharringtonine, a cytotoxic component of the evergreen plant Cephalotaxus harringtonia. Ni D; Ho DH; Vijjeswarapu M; Felix E; Rhea PR; Newman RA J Exp Ther Oncol; 2003; 3(1):47-52. PubMed ID: 12724858 [TBL] [Abstract][Full Text] [Related]
14. Synergistic killing effects of homoharringtonine and arsenic trioxide on acute myeloid leukemia stem cells and the underlying mechanisms. Tan M; Zhang Q; Yuan X; Chen Y; Wu Y J Exp Clin Cancer Res; 2019 Jul; 38(1):308. PubMed ID: 31307525 [TBL] [Abstract][Full Text] [Related]
15. An anticancer agent-loaded PLGA nanomedicine with glutathione-response and targeted delivery for the treatment of lung cancer. Zhang Z; Cheng W; Pan Y; Jia L J Mater Chem B; 2020 Jan; 8(4):655-665. PubMed ID: 31904073 [TBL] [Abstract][Full Text] [Related]
16. Homoharringtonine inhibits melanoma cells proliferation in vitro and vivo by inducing DNA damage, apoptosis, and G2/M cell cycle arrest. Tang JF; Li GL; Zhang T; Du YM; Huang SY; Ran JH; Li J; Chen DL Arch Biochem Biophys; 2021 Mar; 700():108774. PubMed ID: 33548212 [TBL] [Abstract][Full Text] [Related]
17. Doxorubicin-induced mitophagy and mitochondrial damage is associated with dysregulation of the PINK1/parkin pathway. Yin J; Guo J; Zhang Q; Cui L; Zhang L; Zhang T; Zhao J; Li J; Middleton A; Carmichael PL; Peng S Toxicol In Vitro; 2018 Sep; 51():1-10. PubMed ID: 29729358 [TBL] [Abstract][Full Text] [Related]
18. Rhabdoid Tumors Are Sensitive to the Protein-Translation Inhibitor Homoharringtonine. Howard TP; Oberlick EM; Rees MG; Arnoff TE; Pham MT; Brenan L; DoCarmo M; Hong AL; Kugener G; Chou HC; Drosos Y; Mathias KM; Ramos P; Seashore-Ludlow B; Giacomelli AO; Wang X; Freeman BB; Blankenship K; Hoffmann L; Tiv HL; Gokhale PC; Johannessen CM; Stewart EA; Schreiber SL; Hahn WC; Roberts CWM Clin Cancer Res; 2020 Sep; 26(18):4995-5006. PubMed ID: 32631955 [TBL] [Abstract][Full Text] [Related]
19. Mutual Antagonism of PINK1/Parkin and PGC-1α Contributes to Maintenance of Mitochondrial Homeostasis in Rotenone-Induced Neurotoxicity. Peng K; Xiao J; Yang L; Ye F; Cao J; Sai Y Neurotox Res; 2019 Feb; 35(2):331-343. PubMed ID: 30242625 [TBL] [Abstract][Full Text] [Related]
20. Homoharringtonine synergy with oridonin in treatment of t(8; 21) acute myeloid leukemia. Zhang W; Lu Y; Zhen T; Chen X; Zhang M; Liu P; Weng X; Chen B; Wang Y Front Med; 2019 Jun; 13(3):388-397. PubMed ID: 30206768 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]